RazorMetrics Climbs to No. 12 on Deloitte's Technology Fast 500 in 2025
In a significant achievement, RazorMetrics has been named the 12th fastest-growing technology company by Deloitte on its 2025 Technology Fast 500 list. This list highlights the most successful technology, media, telecommunications, life sciences, fintech, and energy tech companies across North America. Founded with the mission of enhancing prescription-drug affordability, RazorMetrics has demonstrated extraordinary growth, placing first in Texas in the life sciences category and second nationwide.
The rankings reflect the company's impressive revenue growth from fiscal years 2021 to 2024, revealing a triple-digit percentage increase. RazorMetrics has capitalized on the rising necessity for health plan sponsors, employers, and brokers to adopt data-driven strategies for reducing prescription drug costs while ensuring no disruption exists in the provider workflow. By identifying safe, cost-effective alternatives for medications, RazorMetrics assists its clients in lowering drug expenses without compromising patient trust or adherence to treatment.
Tom Dorsett, the co-founder and CEO of RazorMetrics, expressed immense pride in this accomplishment, stating, "Ranking 12 among technology companies in the U.S. is a tribute to the dedication and hard work of our entire team. Our success owes a lot to our physician-first methodology and our reliable results."
Dr. Siva Mohan, co-founder and president, highlighted the urgency of addressing soaring drug prices, remarking, "Prescription drug prices are escalating faster than any other area in healthcare. Our inclusion in Deloitte's Technology Fast 500 underscores the crucial services we provide to our clients, working diligently to make healthcare more affordable."
In this pursuit, RazorMetrics has expanded its leadership team, ramped up operations, and strengthened partnerships to accommodate a surge in client demand. Notably, the company achieved over $34 million in drug cost savings across Texas within 24 months, emphasizing its commitment to delivering verified and impactful results.
Deloitte's Wolfe Tone, a partner and leader of the US Deloitte Private Emerging Client Portfolio, remarked on the significance of this year's rankings. He noted that more than half the recognized companies had previous honors, but it was also essential to acknowledge that the top ten featured many first-time entrants. This indicates a dynamic interplay between established players and innovative newcomers across key industries, revealing how private companies remain at the forefront of market competition with their remarkable growth trajectories.
Deloitte's Technology Fast 500 award has been recognizing the fastest-growing companies for over three decades. To qualify, companies must be proprietors of innovative technology that significantly contributes to their operational revenues, and they must meet specific growth criteria. RazorMetrics' innovative approach to pharmacy cost containment deploys proprietary technology that identifies opportunities for cost savings through methods like medication switching and deprescription, facilitating the seamless integration into existing workflows for prescribers. Based in Austin, Texas, RazorMetrics is dedicated to supporting a range of clients, including self-funded employers, health plans, and pharmacy benefit managers (PBMs), by enhancing efficiency and delivering better value in pharmacy benefits. For further information about their solutions, please visit www.razormetrics.com.
As RazorMetrics forges ahead in revolutionizing the pharmacy landscape, its achievements with the Deloitte Technology Fast 500 badge signify not just commendation, but serve as a harbinger of what lies ahead in their journey. The company's commitment to tackling the challenge of prescription costs is part of a larger trend in healthcare technology aimed at fostering affordability and improved patient outcomes.
The rankings reflect the company's impressive revenue growth from fiscal years 2021 to 2024, revealing a triple-digit percentage increase. RazorMetrics has capitalized on the rising necessity for health plan sponsors, employers, and brokers to adopt data-driven strategies for reducing prescription drug costs while ensuring no disruption exists in the provider workflow. By identifying safe, cost-effective alternatives for medications, RazorMetrics assists its clients in lowering drug expenses without compromising patient trust or adherence to treatment.
Tom Dorsett, the co-founder and CEO of RazorMetrics, expressed immense pride in this accomplishment, stating, "Ranking 12 among technology companies in the U.S. is a tribute to the dedication and hard work of our entire team. Our success owes a lot to our physician-first methodology and our reliable results."
Dr. Siva Mohan, co-founder and president, highlighted the urgency of addressing soaring drug prices, remarking, "Prescription drug prices are escalating faster than any other area in healthcare. Our inclusion in Deloitte's Technology Fast 500 underscores the crucial services we provide to our clients, working diligently to make healthcare more affordable."
In this pursuit, RazorMetrics has expanded its leadership team, ramped up operations, and strengthened partnerships to accommodate a surge in client demand. Notably, the company achieved over $34 million in drug cost savings across Texas within 24 months, emphasizing its commitment to delivering verified and impactful results.
Deloitte's Wolfe Tone, a partner and leader of the US Deloitte Private Emerging Client Portfolio, remarked on the significance of this year's rankings. He noted that more than half the recognized companies had previous honors, but it was also essential to acknowledge that the top ten featured many first-time entrants. This indicates a dynamic interplay between established players and innovative newcomers across key industries, revealing how private companies remain at the forefront of market competition with their remarkable growth trajectories.
Deloitte's Technology Fast 500 award has been recognizing the fastest-growing companies for over three decades. To qualify, companies must be proprietors of innovative technology that significantly contributes to their operational revenues, and they must meet specific growth criteria. RazorMetrics' innovative approach to pharmacy cost containment deploys proprietary technology that identifies opportunities for cost savings through methods like medication switching and deprescription, facilitating the seamless integration into existing workflows for prescribers. Based in Austin, Texas, RazorMetrics is dedicated to supporting a range of clients, including self-funded employers, health plans, and pharmacy benefit managers (PBMs), by enhancing efficiency and delivering better value in pharmacy benefits. For further information about their solutions, please visit www.razormetrics.com.
As RazorMetrics forges ahead in revolutionizing the pharmacy landscape, its achievements with the Deloitte Technology Fast 500 badge signify not just commendation, but serve as a harbinger of what lies ahead in their journey. The company's commitment to tackling the challenge of prescription costs is part of a larger trend in healthcare technology aimed at fostering affordability and improved patient outcomes.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.